Publications by authors named "Emma Wijkmark"

Claim this Profile
E
Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non-diabetic chronic kidney disease.
Victor Wasehuus, J David Smeijer, Phil Ambery, Peter J Greasley, Emma Wijkmark

Diabetes Obes Metab· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial.
Hiddo J L Heerspink, Peter J Greasley, Christine Ahlström, Magnus Althage, Jamie P Dwyer, Emma Wijkmark

Nephrol Dial Transplant· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial.
Hiddo J L Heerspink, Arihiro Kiyosue, David C Wheeler, Min Lin, Emma Wijkmark

Lancet· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker responses in eelpouts from four coastal areas in Sweden, Denmark and Germany.
Noomi Asker, Eva Albertsson, Emma Wijkmark, Sara Bergek, Jari Parkkonen

Mar Environ Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A gene to organism approach--assessing the impact of environmental pollution in eelpout (Zoarces viviparus) females and larvae.
Noomi Asker, Bethanie Carney Almroth, Eva Albertsson, Mariateresa Coltellaro, John Paul Bignell, Emma Wijkmark

Environ Toxicol Chem· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis